Interleukin-10 protects against aging-induced endothelial dysfunction

Physiological Reports

Volumn 1, Issue 6, 2013, Pages 1-8

  Kinzenbaw, Dale A ^a   Chu, Yi ^a   Peña Silva, Ricardo A ^a   Didion, Sean P ^a,b   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelium; Interleukin 6; NADPH oxidase; Nitric oxide; Oxidative stress

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; NITROPRUSSIDE SODIUM; STAT3 PROTEIN; TEMPOL;

ADULT; AGING; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; FEMALE; MALE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 85008937462     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.149     Document Type: Article

References (50)

1. Angulo, J., S. Vallejo, M. El Assar, J. Garcia-Septiem, C. F. Sanchez-Ferrer, and L. Rodriguez-Manas. 2012. Age-related differences in the effects of a and c peroxisome proliferator-activated receptor subtype agonists on endothelial vasodilation in human microvessels. Exp. Gerontol. 47: 734–740.
2. Arntzen, K. A., and E. B. Mathiesen. 2011. Subclinical carotid atherosclerosis and cognitive function. Acta Neurol. Scand. Suppl. 1 24 (Suppl. 191): 18–22.
3. Boekholdt, S. M., and E. S. Stroes. 2012. The interleukin-6 pathway and atherosclerosis. Lancet 379: 1176–1178.
4. Brasier, A. R. 2010. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc. Res. 8 6: 211–218.
5. Brown, K. A., Y. Chu, D. D. Lund, D. D. Heistad, and F. M. Faraci. 2006. Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am. J. Physiol. Heart Circ. Physiol. 290: H2600–H2605.
6. Brown, K. A., S. P. Didion, J. J. Andresen, and F. M. Faraci. 2007. Effect of aging, MnSOD deficiency, and genetic background on endothelial function: evidence for MnSOD haploinsufficiency. Arterioscler. Thromb. Vasc. Biol. 27: 1941–1946.
7. Chrissobolis, S., B. Banfi, C. G. Sobey, and F. M. Faraci. 2012. Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. J. Appl. Physiol. 113: 184–191.
8. Chu, Y., D. D. Heistad, K. L. Knudtson, K. G. Lamping, and F. M. Faraci. 2002. Quantification of mRNA for endothelial NO synthase in mouse blood vessels by real-time polymerase chain reaction. Arterioscler. Thromb. Vasc. Biol. 22: 611–616.
9. Didion, S. P., D. A. Kinzenbaw, L. I. Schrader, and F. M. Faraci. 2006. Heterozygous CuZn superoxide dismutase deficiency produces a vascular phenotype with aging. Hypertension 48: 1072–1079.
10. Didion, S. P., D. A. Kinzenbaw, L. I. Schrader, Y. Chu, and F. M. Faraci. 2009. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54: 619–624.
11. Donato, A. J., I. Eskurza, A. E. Silver, A. S. Levy, G. L. Pierce, P. E. Gates, et al. 2007. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ. Res. 100: 1659–1666.
12. Drummond, G. R., S. Selemidis, K. K. Griendling, and C. G. Sobey. 2011. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10: 453–471.
13. Dugan, L. L., S. S. Ali, G. Shekhtman, A. J. Roberts, J. Lucero, K. L. Quick, et al. 2009. IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PLoS ONE 4: e5518.
14. El Assar, M., J. Angulo, S. Vallejo, C. Peiro, C. F. Sanchez-Ferrer, and L. Rodriguez-Manas. 2012. Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol. 3: 132.
15. Faraci, F. 2011a. Cerebral vascular dysfunction with aging. Pp. 4 05–418 in E. J. Masoro, S. N. Austad, eds. Handbook of the Biology of Aging. Academic Press, London.
16. Faraci, F. M. 2011b. Protecting against vascular disease in brain. Am. J. Physiol. Heart Circ. Physiol. 300: H1566–H1582.
17. Faraci, F. M., C. D. Sigmund, E. G. Shesely, N. Maeda, and D. D. Heistad. 1998. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am. J. Physiol. 274: H564–H570.
18. Fleenor, B. S., D. R. Seals, M. L. Zigler, and A. L. Sindler. 2012. Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell 11: 269–276.
19. Fogel, B., and J. S. Pober. 2012. Vascular endothelial cells as immunological targets in atherosclerosis. Pp. 87–114 in G. Wick, C. Grundtman, eds. Inflammation and Atherosclerosis. Springer, Wien, New York, NY.
20. Forsey, R. J., J. M. Thompson, J. Ernerudh, T. L. Hurst, J. Strindhall, B. Johansson, et al. 2003. Plasma cytokine profiles in elderly humans. Mech. Ageing Dev. 124: 487–493.
21. Frank, M. G., R. M. Barrientos, J. C. Biedenkapp, J. W. Rudy, L. R. Watkins, and S. F. Maier. 2006. mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol. Aging 27: 717–722.
22. Gunnett, C. A., D. J. Berg, and F. M. Faraci. 1999. Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke 30: 2191–2195.
23. Gunnett, C. A., D. D. Heistad, D. J. Berg, and F. M. Faraci. 2000. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am. J. Physiol. Heart Circ. Physiol. 279: H1555–H1562.
24. Gunnett, C. A., D. D. Heistad, and F. M. Faraci. 2002. Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide. Diabetes 51: 1931–1937.
25. Johnson, A. W., D. A. Kinzenbaw, M. L. Modrick, and F. M. Faraci. 2013. Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension. Hypertension 61: 437–442.
26. Lakatta, E. G., and D. Levy. 2003. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: aging arteries: a “set up” for vascular disease. Circulation 107: 139–146.
27. Lamping, K. G., and F. M. Faraci. 2001. Role of sex differences and effects of endothelial NO synthase deficiency in responses of carotid arteries to serotonin. Arterioscler. Thromb. Vasc. Biol. 2 1: 523–528.
28. Lauer, T., M. Preik, T. Rassaf, B. E. Strauer, A. Deussen, M. Feelisch, et al. 2001. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc. Natl. Acad. Sci. USA 98: 12814–12819.
29. Libby, P., P. M. Ridker, and G. K. Hansson. 2011. Progress and challenges in translating the biology of atherosclerosis. Nature 473: 317–325.
30. Lorenz, M. W., H. S. Markus, M. L. Bots, M. Rosvall, and M. Sitzer. 2007. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115: 459–467.
31. Lund, D. D., Y. Chu, J. D. Miller, and D. D. Heistad. 2009. Protective effect of extracellular superoxide dismutase on endothelial function during aging. Am. J. Physiol. Heart Circ. Physiol. 296: H1920–H1925.
32. Mayhan, W. G., D. M. Arrick, G. M. Sharpe, and H. Sun. 2008. Age-related alterations in reactivity of cerebral arterioles: role of oxidative stress. Microcirculation 15: 225–236.
33. Miwa, K., M. Tanaka, S. Okazaki, S. Furukado, M. Sakaguchi, H. Mochizuki, et al. 2013. Association between interleukin-6 levels and first-ever cerebrovascular events in patients with vascular risk factors. Arterioscler. Thromb. Vasc. Biol. 33: 400–405.
34. Modrick, M. L., S. P. Didion, C. D. Sigmund, and F. M. Faraci. 2009. Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. Am. J. Physiol. Heart Circ. Physiol. 296: H1914–H1919.
35. Modrick, M. L., D. A. Kinzenbaw, Y. Chu, C. D. Sigmund, and F. M. Faraci. 2012. Peroxisome proliferator-activated receptor-gamma protects against vascular aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302: R1184–R1190.
36. Ouyang, W., S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2 9: 71–109.
37. Park, L., J. Anrather, H. Girouard, P. Zhou, and C. Iadecola. 2007. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J. Cereb. Blood Flow Metab. 27: 1908–1918.
38. Pena Silva, R. A., Y. Chu, J. D. Miller, I. J. Mitchell, J. M. Penninger, F. M. Faraci, et al. 2012. Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging. Stroke43: 3358–3363.
39. Rodriguez-Manas, L., M. El-Assar, S. Vallejo, P. Lopez-Doriga, J. Solis, R. Petidier, et al. 2009. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell 8: 226–238.
40. Rojas, M., W. Zhang, D. L. Lee, M. J. Romero, D. T. Nguyen, M. Al-Shabrawey, et al. 2010. Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Invest. Ophthalmol. Vis. Sci. 5 1: 1709–1718.
41. Rothwell, P. M., A. J. Coull, L. E. Silver, J. F. Fairhead, M. F. Giles, C. E. Lovelock, et al. 2005. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366: 1773–1783.
42. Saito, H., E. R. Sherwood, T. K. Varma, and B. M. Evers. 2003. Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech. Ageing Dev. 124: 1047–1058.
43. Schrader, L. I., D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion. 2007. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler. Thromb. Vasc. Biol. 27: 2576–2581.
44. Sikka, G., K. L. Miller, J. Steppan, D. Pandey, S. M. Jung, C. D. 3rd Fraser, et al. 2013. Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age. Exp. Gerontol. 48: 128–135.
45. Tabas, I., and C. K. Glass. 2013. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339: 166–172.
46. Toth, P., Z. Tucsek, D. Sosnowska, T. Gautam, M. Mitschelen, S. Tarantini, et al. 2013. Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. J. Cereb. Blood Flow Metab. (doi: 10.1038/jcbfm.2013.143)
47. Walker, A. E., G. D. Henson, K. D. Reihl, E. I. Nielson, R. G. Morgan, L. A. Lesniewski, et al. 2013. Beneficial effects of lifelong caloric restriction on endothelial function are greater in conduit arteries compared to cerebral resistance arteries. Age. (doi: 10.1007/s11357-013-9585-0)
48. Wassmann, S., M. Stumpf, K. Strehlow, A. Schmid, B. Schieffer, M. Bohm, et al. 2004. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ. Res. 94: 534–541.
49. Wendell, C. R., A. B. Zonderman, E. J. Metter, S. S. Najjar, and S. R. Waldstein. 2009. Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 40: 3180–3185.
50. Wray, D. W., S. K. Nishiyama, R. A. Harris, J. Zhao, J. McDaniel, A. S. Fjeldstad, et al. 2012. Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption. Hypertension 59: 818–824.